James B Hengenius1, Nicolaas I Bohnen2, Andrea Rosso1, Theodore J Huppert3, Caterina Rosano1. 1. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. 2. Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA. 3. Department of Electrical and Computer Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Abstract
BACKGROUND AND PURPOSE: Mild Parkinsonian signs (MPS) are common in older adults. We hypothesized that MPS are associated with lower functional connectivity (FC) in dopamine-dependent cortico-striatal networks, and these associations vary with white matter hyperintensity (WMH), a risk factor for MPS. METHODS: We examined resting-state functional MRI in 266 participants (mean age 83; 57% female; 41% African American) with data on MPS (Unified Parkinson's Disease Rating Scale), demographics, cognition, muscle-skeletal, and cardiometabolic health. FC between cortex and striatum was examined separately for sensorimotor, executive, and limbic functional subregions. Logistic regression tested the association of FC in each network with MPS, adjusted for covariates. Interactions of FC by WMH were tested; and analyses were repeated stratified by WMH above/below the median. RESULTS: Compared to those without MPS, those with MPS had lower cortico-striatal FC in the left executive network (adjusted odds ratio [95% confidence interval], p-value: 0.188 [0.043, 0.824], .027). The interaction with WMH was p = .064; left executive FC was inversely associated with MPS for high WMH (0.077 [0.010, 0.599], .014) but not low WMH participants (1.245 [0.128, 12.132], .850). CONCLUSIONS: MPS appear related to lower executive network FC, robust to adjustment for other risk factors, and stronger for those with higher burden of WMH. Future longitudinal studies should examine the interplay between cerebral small vessel disease and connectivity influencing MPS.
BACKGROUND AND PURPOSE: Mild Parkinsonian signs (MPS) are common in older adults. We hypothesized that MPS are associated with lower functional connectivity (FC) in dopamine-dependent cortico-striatal networks, and these associations vary with white matter hyperintensity (WMH), a risk factor for MPS. METHODS: We examined resting-state functional MRI in 266 participants (mean age 83; 57% female; 41% African American) with data on MPS (Unified Parkinson's Disease Rating Scale), demographics, cognition, muscle-skeletal, and cardiometabolic health. FC between cortex and striatum was examined separately for sensorimotor, executive, and limbic functional subregions. Logistic regression tested the association of FC in each network with MPS, adjusted for covariates. Interactions of FC by WMH were tested; and analyses were repeated stratified by WMH above/below the median. RESULTS: Compared to those without MPS, those with MPS had lower cortico-striatal FC in the left executive network (adjusted odds ratio [95% confidence interval], p-value: 0.188 [0.043, 0.824], .027). The interaction with WMH was p = .064; left executive FC was inversely associated with MPS for high WMH (0.077 [0.010, 0.599], .014) but not low WMH participants (1.245 [0.128, 12.132], .850). CONCLUSIONS: MPS appear related to lower executive network FC, robust to adjustment for other risk factors, and stronger for those with higher burden of WMH. Future longitudinal studies should examine the interplay between cerebral small vessel disease and connectivity influencing MPS.
Authors: Michael D Fox; Abraham Z Snyder; Justin L Vincent; Maurizio Corbetta; David C Van Essen; Marcus E Raichle Journal: Proc Natl Acad Sci U S A Date: 2005-06-23 Impact factor: 11.205
Authors: Cameron Miller-Patterson; Jennifer Han; Kristine Yaffe; Andrea L Rosso; Lenore J Launer; Stephen B Kritchevsky; Robert M Boudreau; Caterina Rosano Journal: Parkinsonism Relat Disord Date: 2020-05-22 Impact factor: 4.891
Authors: Minjie Wu; Caterina Rosano; Meryl Butters; Ellen Whyte; Megan Nable; Ryan Crooks; Carolyn C Meltzer; Charles F Reynolds; Howard J Aizenstein Journal: Psychiatry Res Date: 2006-11-13 Impact factor: 3.222
Authors: Andrea L Rosso; Stephanie A Studenski; Wen G Chen; Howard J Aizenstein; Neil B Alexander; David A Bennett; Sandra E Black; Richard Camicioli; Michelle C Carlson; Luigi Ferrucci; Jack M Guralnik; Jeffrey M Hausdorff; Jeff Kaye; Lenore J Launer; Lewis A Lipsitz; Joe Verghese; Caterina Rosano Journal: J Gerontol A Biol Sci Med Sci Date: 2013-07-10 Impact factor: 6.053
Authors: Martin Kronenbuerger; Jun Hua; Jee Y A Bang; Kia E Ultz; Xinyuan Miao; Xiaoyu Zhang; James J Pekar; Peter C M van Zijl; Wenzhen Duan; Russell L Margolis; Christopher A Ross Journal: Neurodegener Dis Date: 2019-08-14 Impact factor: 2.977
Authors: Aron S Buchman; Sue E Leurgans; Lei Yu; Robert S Wilson; Andrew S Lim; Bryan D James; Joshua M Shulman; David A Bennett Journal: Neurology Date: 2016-08-03 Impact factor: 9.910
Authors: Joey A Contreras; Andrea Avena-Koenigsberger; Shannon L Risacher; John D West; Eileen Tallman; Brenna C McDonald; Martin R Farlow; Liana G Apostolova; Joaquín Goñi; Mario Dzemidzic; Yu-Chien Wu; Daniel Kessler; Lucas Jeub; Santo Fortunato; Andrew J Saykin; Olaf Sporns Journal: Neuroimage Clin Date: 2019-01-22 Impact factor: 4.881